Using a randomized controlled trial (RCT) design, the main objective of this study is to evaluate the clinical, patient-centered, and economic effectiveness of a stepped-care intervention for patients with panic attacks and panic disorder presenting to the busiest Accident and Emergency (A\&E) departments of the largest public healthcare group in Singapore. The RCT will have two arms: 1) treatment via an enhanced care pathway consisting of a stepped-care intervention for panic attacks and panic disorder; and 2) a control arm consisting of screening for panic attacks and panic disorder in the A\&E and discharge (routine care). In addition to the baseline assessment, the study follow-up visits will occur at 1, 3, 6, and 12 months.
Specific Aims and Hypotheses Aim 1 (Primary): To evaluate the clinical effectiveness of a stepped-care intervention for A\&E patients with panic attacks and panic disorder as compared to screening alone. Aim 2: To evaluate the patient-centered effectiveness of a stepped-care intervention for A\&E patients with panic attacks and panic disorder as compared to screening alone. Aim 3: To evaluate the incremental cost-effectiveness of a stepped-care intervention for A\&E patients with panic attacks and panic disorder compared to screening alone from the health system perspective.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
79
A stepwise progression of intervention according to the participant's response to the increasing levels of therapy. There will be 1 session of psychoeducation, followed by 5 sessions of Cognitive Behavioral Therapy (CBT) if panic symptoms do not improve at 1-month follow-up.
Screening for probable panic attacks or panic disorder using the Structured Clinical Interview for DSM-5
Singapore General Hospital
Singapore, Singapore
Change in panic scores at every 3 months from baseline using the Panic Disorder Severity Scale (PDSS; Shear et al., 2001)
The PDSS is a 7-item semi-structured interview of panic symptom severity. Each item is rated on a 0 (none/mild) to 4 (extreme/severe) scale. A higher total score would represent severe panic symptoms.
Time frame: Baseline, 1st month, 3rd month, 6th month, 12th month
Short Form Health Survey (SF-36; Ware & Sherbourne, 1992)
The SF-36 is a reliable and valid 36-item self-report questionnaire that evaluates multiple facets of health-related quality of life.
Time frame: Baseline, 1st month, 3rd month, 6th month, 12th month
WHO Disability Assessment Schedule (WHO-DAS; World Health Organization, 2010)
The WHO-DAS is a brief, cross-culturally valid, self-report questionnaire that is used to assess overall level of health and disability in clinical and general population settings.
Time frame: Baseline, 1st month, 3rd month, 6th month, 12th month
Psychiatric Diagnostic Screening Questionnaire (PDSQ; Zimmerman & Mattia, 2001)
The PDSQ is a reliable and valid self-report diagnostic questionnaire that has been widely used to assess the most common psychiatric disorders in outpatient settings.
Time frame: Baseline, 1st month, 3rd month, 6th month, 12th month
EQ-5D (EuroQol Group, 1990)
The EQ-5D is a patient self-report instrument that evaluates generic quality of life.
Time frame: Baseline, 1st month, 3rd month, 6th month, 12th month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.